Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

158

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01EA02	SPRYCEL	B	Dasatinib - 70mg	70mg	Tablet	212,274,841 L.L
L01EA02	SPRYCEL	B	Dasatinib - 50mg	50mg	Tablet	212,274,841 L.L
J02AC01	STABILANOL	G	Fluconazole - 2mg/ml	2mg/ml	Injectable solution	1,291,789 L.L
J02AC01	STABILANOL	G	Fluconazole - 100mg	100mg	Capsule	1,432,331 L.L
J02AC01	STABILANOL	G	Fluconazole - 150mg	150mg	Capsule	264,637 L.L
M04AA03	STABURIC	G	Febuxostat - 120mg	120mg	Tablet, film coated	1,420,889 L.L
M04AA03	STABURIC	G	Febuxostat - 80mg	80mg	Tablet, film coated	1,355,489 L.L
M04AA03	STABURIC	G	Febuxostat - 40mg	40mg	Tablet, film coated	1,081,345 L.L
V01AA	STALORAL	B	Allergen extracts - 2 x 100IR ou IC/ml		Solution	8,449,319 L.L
V01AA	STALORAL	B	Allergen extracts - 300 IR ou IC/ml		Solution	6,598,267 L.L
V01AA	STALORAL	B	Allergen extracts - 10-100-100 IR ou IC/ml	10-100-100 IR ou IC/ml	Solution	9,129,688 L.L
V01AA	STALORAL	B	Allergen extracts - 10-300 IR ou IC/ml	10-300 IR ou IC/ml	Solution	7,206,963 L.L
C10AA03	STAVACOR	G	Pravastatin sodium - 40mg	40mg	Tablet, scored	891,799 L.L
C10AA03	STAVACOR	G	Pravastatin sodium - 20mg	20mg	Tablet, scored	725,419 L.L
C10AA03	STAVACOR	G	Pravastatin sodium - 10mg	10mg	Tablet, scored	1,695,801 L.L
C10AA01	STAVINE	G	Simvastatin - 10mg	10mg	Tablet	207,336 L.L
C10AA01	STAVINE	G	Simvastatin - 20mg	20mg	Tablet	207,336 L.L
C10AA01	STAVINE	G	Simvastatin - 40mg	40mg	Tablet, scored	207,336 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	157,788,141 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	157,788,141 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	157,788,141 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	157,788,141 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 130mg	130mg	Injectable concentrate for solution	235,593,517 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 130mg	130mg	Injectable concentrate for solution	L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	L.L
G04CB01	STERIBO	G	Finasteride - 1mg	1mg	Tablet, film coated	2,636,619 L.L
G04CB01	STERIFINE 5	G	Finasteride - 5mg	5mg	Tablet, film coated	733,354 L.L
V07AB01	STERILE WATER FOR INJECTION	G	Water for Injection -		Water for injection, irrigation	188,772 L.L
V07AB01	STERILE WATER FOR INJECTION	G	Water for Injection -		Water for injection, irrigation	203,481 L.L

...

158

...